The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire. - Wikidata - wikimedia - TriplyDB

The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.

The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.

http://www.wikidata.org/entity/Q34777433

about

Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability.Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa.Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection How HIV treatment could result in effective prevention Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire.First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.When to start antiretroviral therapy in resource-limited settings.Assessment of duration of staying free from acquiring rehappening opportunistic infections among pre-ART people living with HIV/AIDS between 2008 and 2013.Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008 Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness Morbidity and mortality according to latest CD4+ cell count among HIV positive individuals in South Africa who enrolled in project Phidisa Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials.Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India.Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age.Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa.Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy Scaling up antiretroviral therapy in South Africa: the impact of speed on survival.Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies.Lives saved by expanding HIV treatment availability in resource-limited settings: the example of Haiti.Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis.The survival benefits of antiretroviral therapy in South Africa.Immunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study.Clinical Impact and Cost-effectiveness of Diagnosing HIV Infection During Early Infancy in South Africa: Test Timing and Frequency.The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis.Antiretroviral treatment Long-Term (ALT) cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda.

P2860

Q28476337-1069A957-E0A8-4750-8453-586A2E5221C9 Q28476684-55AA5187-F213-4011-9059-E2209FFB4FB9 Q28483035-79478FCF-4C1F-44F3-BE7D-4897D3A49F40 Q30528513-D6369AF2-D432-4803-A94A-BC266BB4A3AD Q33670446-B23CC5F9-0B1F-414F-8642-A594C27D019D Q33973857-181C9B65-5814-4E86-AD7C-E2370ACFA193 Q34090397-6F543602-B223-41D6-BBB6-105B31B37321 Q34097961-C6DE058E-B71F-44CB-A5C8-F1E67E8755BA Q34748599-F386556C-1E7A-4D99-B725-1C242B25DB3C Q34974260-2BC62E53-7814-43E7-8215-1684C2FB039C Q35037628-ED0DBEC9-71A0-486F-A983-7A775E8D86AC Q35076875-6E75B4CE-1D37-4BD5-9492-A27E4F835C98 Q35217495-98977B43-91D1-4759-ABA0-CB67C650A7CE Q35345807-2EFF2DF1-2222-47F0-971E-FB1FCDEC7D66 Q35409929-6060A1D1-95D9-4919-B4D6-5D015B8F3B28 Q35562938-967519A8-9F72-480C-8D79-3E9C52937749 Q35575721-7CD5576E-BF25-42BF-850F-1A6DDA4F3D24 Q35955127-783DA949-EBC6-43B6-900C-B6DF65963986 Q36179320-1B78C3C5-5F1F-4ED6-A55A-9C2D2FC92BCF Q36555263-DD51C77F-1EEF-448E-B205-1FC568BBB06C Q36628019-8F87E1A7-3502-4738-8B55-4491F61E062E Q36711798-8B908989-D61B-4B4A-A63E-8838BD96E918 Q36915084-EF395EEC-0875-475C-8633-9B39C2DE6016 Q37290659-C600AE3F-D930-4082-9272-908BAF989444 Q37483442-F5491979-644C-4CD0-8A4C-CFDFED48E511 Q37520212-88908C8E-A4A1-4709-943F-AD6B728215C2 Q39132282-2AA650D3-E145-4D31-99BA-6FD122F75FA9 Q40570261-C035EB92-4FE0-42DC-83ED-D2D2AE470DFF Q45734772-0809EAFF-5A94-4A5D-9F43-52A06E13E6CE Q51368363-79BDD658-F5CD-4836-B575-5C59F280CC08

P2860

The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.

http://www.wikidata.org/entity/Q34777433

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

The independent effect of high ...... ected adults in Côte d'Ivoire.

@ast

The independent effect of high ...... ected adults in Côte d'Ivoire.

@en

The independent effect of high ...... ected adults in Côte d'Ivoire.

@nl

type

label

The independent effect of high ...... ected adults in Côte d'Ivoire.

@ast

The independent effect of high ...... ected adults in Côte d'Ivoire.

@en

The independent effect of high ...... ected adults in Côte d'Ivoire.

@nl

prefLabel

The independent effect of high ...... ected adults in Côte d'Ivoire.

@ast

The independent effect of high ...... ected adults in Côte d'Ivoire.

@en

The independent effect of high ...... ected adults in Côte d'Ivoire.

@nl

P1433

Q34777433-AADC5097-8F2F-4749-8189-E85BAF0A1BF6

P1476

Q34777433-A8E9E4DC-2A25-443B-83DB-6BCB4691CDB1

P2093

Q34777433-15491060-B85C-460E-8528-BC5BA2ACE820

Q34777433-39CE19FF-6D9F-4EE2-8FF4-97D503881C25

Q34777433-800AD910-E332-4970-A111-14229F07A825

Q34777433-9EA0D395-AAA9-49A3-8B04-EAC44EAB6B27

Q34777433-BEC2D8D5-DECC-4C18-857B-8F4C628EA98F

Q34777433-D845BEA3-4F59-4481-B267-8D344861CCFC

Q34777433-E0C3122C-2B39-448F-9278-8903DF6FA0A6

P2860

Q34777433-0051E995-6B9A-4686-A4A0-DD79148A95C2

Q34777433-05A570D5-5A0B-4E17-BA7F-2188A322B3F3

Q34777433-07A1AAF3-34A0-422F-B9A8-FF9B7CE7E4A6

Q34777433-0C63502F-9909-4D1E-AAE3-BD6EBEF002D6

Q34777433-19F05060-1B74-4507-BE81-E8D49D720D4B

Q34777433-2B7DC201-6CB4-4517-837A-517EAC9FF978

Q34777433-399EFBFD-CBC2-413F-B38A-944CC66F8406

Q34777433-448FDF45-1A38-4DE0-A897-AC9DD5EFD052

Q34777433-4DEC3EE2-50DB-43AB-BF25-892FE3655A7B

Q34777433-533BB08B-ACE7-49CA-B995-4E347ED9BA42

P304

Q34777433-3BC1FAF7-B47F-49B5-AA75-90204A090618

P31

Q34777433-D01C344A-22C6-4F23-9576-B7A695AC6C96

P433

Q34777433-7F8632C3-32B8-4EC2-A93D-4971EB342C38

P478

Q34777433-62CB7192-7D7F-4646-AE0B-9B9C3A3A7AB7

P50

Q34777433-011D3A28-ED7A-4B07-9B41-96CFAD20A2A2

Q34777433-2876B9AA-DD95-4C6D-BB88-B5AE2FD4FB56

Q34777433-61740A5F-7375-437B-9115-0A16A1907812

P577

Q34777433-CFE9592B-F345-4FB3-A949-67BD6E243732

P698

Q34777433-023A74E1-6C7E-4492-8194-8BD193AB8360

P921

Q34777433-0BAA1469-F82E-42D6-B155-4B416B4F7455

Q34777433-FE87566D-87D5-4D03-ADB7-EB3DD9AEB191

P932

Q34777433-EF431B72-4DFE-40D6-B4E8-960EAAE4CAEE

P1433

Antiviral Therapy

P1476

The independent effect of high ...... fected adults in Côte d'Ivoire

@en

P2093

Bingxia Wang

http://www.w3.org/2001/XMLSchema#string

Catherine Seyler

http://www.w3.org/2001/XMLSchema#string

Elena Losina

http://www.w3.org/2001/XMLSchema#string

Eugène Messou

http://www.w3.org/2001/XMLSchema#string

Lindsey L Wolf

http://www.w3.org/2001/XMLSchema#string

Sylvie Deuffic-Burban

http://www.w3.org/2001/XMLSchema#string

Yazdan Yazdanpanah

http://www.w3.org/2001/XMLSchema#string

P2860

Review of Human Immunodeficiency Virus Type 1–Related Opportunistic Infections in Sub‐Saharan Africa

Longitudinal data analysis for discrete and continuous outcomes

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group.

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.

Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.

P304

543-551

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Xavier Anglaret

Delphine Gabillard

Kenneth A Freedberg

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17668563

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3073611

http://www.w3.org/2001/XMLSchema#string